U.S. Centers for Disease Control and Prevention

Company's HIV-resistance Test Receives Approval from FDA

September 27, 2001

Visible Genetics, Inc. said yesterday that the FDA had approved its genetic test for HIV resistance. The TruGene test is the first agency-approved test for analyzing weaknesses in a patient's strain of HIV. It can help doctors pick the AIDS drugs that are likely to be the most effective against the virus.

Back to other CDC news for September 27, 2001

Previous Updates | Search the CDC archive

Adapted from:
Seattle Post-Intelligencer
09.27.01; Bloomberg News

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

My Health Tracker

Join Us on Facebook

Widgets and RSS Feeds

U.S. ASO Finder

CROI 2010 Wrap-Up: The HIV Drug Development Pipeline

CROI 2010 Wrap-Up: The Evolution of Antiretroviral Therapy

This Positive Life: An Interview With Gary

HIV Vaccine Trial Lessons: What Researchers Learned From the STEP Study's Failure and the RV144 ("Thai") Study's Success

Why There's Such an HIV/AIDS Disparity Among U.S. Blacks and Hispanics -- and What to Do About It

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.